Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Fangyi Zhao, PhD
JCP
Original Research
Pharmacogenomic Associations With Weight Gain in Olanzapine Treatment of Patients Without Schizophrenia
August 15, 2012
John P. Houston
,
Jared Kohler
,
Jeffrey R. Bishop
, et al
JCP
Original Research
Analysis of Gene Variants Previously Associated With Iloperidone Response in Patients With Schizophrenia Who Are Treated With Risperidone
July 12, 2011
Bonnie A. Fijal
,
Virginia L. Stauffer
,
Bruce J. Kinon
, et al
JCP
Original Research
A Dose Comparison of Olanzapine for the Treatment of Borderline Personality Disorder: A 12-Week Randomized, Double-Blind, Placebo-Controlled Study
April 5, 2011
Mary C. Zanarini
,
S. Charles Schulz
,
Holland C. Detke
, et al
JCP
Original Research
Longer Time to Antipsychotic Treatment Discontinuation for Any Cause Is Associated With Better Functional Outcomes for Patients With Schizophrenia, Schizophreniform Disorder, or Schizoaffective Disorder
August 15, 2007
Eduardo Dunayevich
,
Haya Ascher-Svanum
,
Fangyi Zhao
, et al
